Precision Biologics Selected To Present Encouraging Clinical Results From Phase 1-2 Study Of NPC-1C At The Annual Meeting Of The American Society of Clinical Oncology

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Precision Biologics, in collaboration with investigators from Duke University, Johns Hopkins, and the University of Texas Southwestern, has been selected to present an abstract of findings from its Phase 1-2 clinical trial at the Annual Meeting of the American Society of Clinical Oncology. The meeting will be held May 30 – June 3, 2014 at the McCormick Place Convention Center in Chicago, Illinois.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC